AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 64 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | +125.0% | 34,478 | +125.4% | 0.00% | – |
| Q2 2022 | $8,000 | -97.5% | 15,299 | -62.9% | 0.00% | -100.0% |
| Q4 2019 | $315,000 | -0.6% | 41,193 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $317,000 | -49.5% | 41,193 | -55.1% | 0.00% | -50.0% |
| Q2 2019 | $628,000 | -13.4% | 91,709 | +1.8% | 0.00% | -33.3% |
| Q1 2019 | $725,000 | -22.2% | 90,109 | -27.6% | 0.00% | -25.0% |
| Q4 2018 | $932,000 | -67.5% | 124,408 | -58.5% | 0.00% | -60.0% |
| Q3 2018 | $2,866,000 | -16.8% | 299,436 | -8.0% | 0.01% | -28.6% |
| Q2 2018 | $3,445,000 | – | 325,611 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |